In this study, HMGCR, a rate‐limiting enzyme of cholesterol biosynthesis, was identified as a potential substrate for CMA, and the abnormal degradation of HMGCR induced by CMA deficiency was found to be mainly responsible for cholesterol accumulation in NASH. The gene discussed is HMGCR; the disease is metabolic dysfunction-associated steatohepatitis.